NEOGEN CORP

NEOG

NEOGEN CORP

NEOG

Insider Sentiment (TTM):

Last Purchase:2026-02-17Last Sale:2023-10-13Shares Purchased (TTM):361Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:212,199,260Shares Outstanding:217,668,392Institutional Ownership Pct.:97.49%

Earnings Market Reaction:

Filing Date:2026-04-09Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in In Vitro & In Vivo Diagnostic Substances

IDXX LNTH NTLA QDEL MYGN ACHV

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31	2023-05-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	160	145	139	129	128	140	120	171	161	206	179	163
Marketable Securities Current	-	-	-	0	0	0	0	0	7	25	60	82
Accounts Receivable Net Current	137	132	138	153	160	164	168	173	174	150	138	153
Inventory Net
Inventory Raw Materials	56	58	67	-	75	75	77	-	-	-	-	-
Inventory Work In Process	9	11	12	-	14	14	13	-	-	-	-	-
Inventory Finished Goods	113	109	132	-	136	128	126	-	-	-	-	-
Inventory Gross	178	177	210	-	226	218	216	-	-	-	-	-
Inventory Valuation Reserves	-17	-15	-17	-	-20	-20	-17	-	-	-	-	-
Inventory Net	162	163	193	191	205	198	199	189	182	161	141	134
Prepaid Expense And Other Assets Current	63	58	53	53	58	68	54	56	78	83	66	53
Assets Of Disposal Group Including Discontinued Op…	68	77	0	50	-	-	-	0	-	-	-	-
Assets Current	590	575	524	577	552	570	541	589	602	624	584	586
Property Plant And Equipm…
Land And Land Improvements	-	-	-	11	-	-	-	10	-	-	-	10
Buildings And Improvements Gross	-	-	-	109	-	-	-	108	-	-	-	97
Machinery And Equipment Gross	-	-	-	181	-	-	-	176	-	-	-	153
Furniture And Fixtures Gross	-	-	-	8	-	-	-	8	-	-	-	7
Construction In Progress Gross	-	-	-	186	-	-	-	114	-	-	-	52
Property Plant And Equipment Gross	-	-	-	495	-	-	-	417	-	-	-	319
Accumulated Depreciation Depletion And Amortizatio…	-	-	-	-155	-	-	-	-140	-	-	-	-120
Property Plant And Equipment Net	332	332	346	339	328	311	301	277	272	244	221	199
Other Assets Noncurrent
Operating Lease Right Of Use Asset	16	15	17	17	17	17	14	15	15	15	15	12
Goodwill	1,048	1,046	1,066	1,065	1,672	1,673	2,137	2,136	2,136	2,138	2,138	2,137
Other Indefinite Lived Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	14
Intangible Assets Net Excluding Goodwill	-	-	-	-	1,439	1,463	1,490	-	1,540	1,565	1,588	-
Finite Lived Intangible Assets Net	1,342	1,359	1,389	1,410	-	-	-	1,512	-	-	-	1,591
Other Assets Noncurrent	32	33	36	35	29	20	20	20	16	16	16	15
Other Assets	2,437	2,453	2,508	2,528	-	-	-	3,682	-	-	-	3,770
Assets	3,359	3,360	3,378	3,444	4,036	4,054	4,503	4,549	4,582	4,602	4,561	4,554
Liabilities And Stockhold…
Liabilities Current
Long Term Debt Current	-	-	-	19	-	-	-	2	-	-	-	-
Finance Lease Liability Current	0	0	0	-	3	3	3	2	3	3	3	-
Accounts Payable Current	75	63	77	80	72	80	61	83	90	112	90	77
Employee Related Liabilities Current	24	20	20	14	18	16	16	20	20	16	15	25
Accrued Income Taxes Current	10	9	9	6	13	11	11	10	12	10	5	7
Interest Payable Current	4	11	4	11	3	11	4	11	3	11	3	11
Deferred Revenue Current	4	4	6	6	6	6	6	5	5	5	4	5
Other Accrued Liabilities Current	-	-	-	-	-	-	-	-	25	20	18	21
Other Liabilities Current	28	31	31	32	26	25	22	23	-	-	-	21
Liabilities Of Disposal Group Including Discontinu…	6	9	0	7	-	-	-	-	-	-	-	-
Liabilities Current	151	147	146	174	141	151	123	154	158	177	138	145
Deferred Income Tax Liabilities Net	269	274	277	281	301	302	318	327	354	355	355	353
Long Term Debt Noncurrent	793	793	793	875	891	890	889	888	888	887	886	885
Other Liabilities Noncurrent	44	42	44	43	43	42	39	35	37	36	36	36
Liabilities	1,257	1,255	1,260	1,373	1,376	1,385	1,368	1,405	1,436	1,455	1,415	1,420
Stockholders Equity
Preferred Stock Value	-	-	0	-	0	0	0	0	0	0	0	0
Common Stock Value	35	35	35	35	35	35	35	35	35	35	35	35
Additional Paid In Capital	2,613	2,611	2,607	2,602	2,598	2,592	2,589	2,584	2,580	2,575	2,572	2,568
Accumulated Other Comprehensive Income Loss Net Of…	-13	-26	-23	-29	-48	-45	-31	-30	-29	-25	-26	-33
Retained Earnings Accumulated Deficit	-533	-516	-500	-536	76	87	543	556	561	563	567	565
Stockholders Equity	2,102	2,104	2,119	2,071	2,660	2,669	3,135	3,144	3,146	3,148	3,146	3,134
Liabilities And Stockholders Equity	3,359	3,360	3,378	3,444	4,036	4,054	4,503	4,549	4,582	4,602	4,561	4,554
Trading Securities Debt Amortized Cost	-	-	-	-	-	-	-	0	-	-	-	84
Allowance For Doubtful Accounts Receivable Current	4	4	5	-	5	5	4	-	4	3	3	-
Preferred Stock Par Or Stated Value Per Share	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16
Common Stock Shares Authorized	630	630	630	630	630	630	630	630	630	630	630	630
Common Stock Shares Issued	218	218	217	217	217	217	217	217	217	217	216	216
Shares Outstanding	218	218	217	217	217	217	217	217	217	217	216	216

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-9.00%	-11.80%	5.16%	5.25%	15.65%	-10.40%	-5.08%	-10.66%	-4.58%	-	-	-
2025	4.71%	2.83%	-9.86%	-8.71%	-8.45%	-31.34%	14.54%	16.73%	-5.78%	20.00%	19.36%	25.11%
2024	-1.49%	8.59%	25.22%	-14.03%	-5.45%	-13.20%	-7.82%	0.84%	19.86%	-4.55%	-0.68%	-17.52%
2023	-	-	-	-	-	-	-	-	-	-18.16%	-28.15%	-33.64%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31	2023-05-31
Liquidity Ratios
Current Ratio	3.92	3.91	3.58	3.32	3.91	3.77	4.41	3.82	3.82	3.54	4.23	4.03
Quick Ratio	2.42	2.41	1.90	1.91	2.04	2.01	2.35	2.23	2.17	2.16	2.73	2.74
Working Capital	439.40M	427.53M	377.86M	402.93M	410.51M	419.25M	417.96M	434.91M	444.63M	447.76M	445.66M	440.46M
Leverage & Debt
Debt to Equity	0.60	0.60	0.59	0.66	0.52	0.52	0.44	0.45	0.46	0.46	0.45	0.45
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-	-	38.72
Debt Ratio	0.37	0.37	0.37	0.40	0.34	0.34	0.30	0.31	0.31	0.32	0.31	0.31
Efficiency & Turnover
Asset Turnover TTM	0.24	0.24	0.23	0.22	0.21	0.21	0.20	0.20	0.20	0.20	0.33	0.30
Days Sales Outstanding TTM	62.30	61.38	62.99	66.58	67.21	62.83	61.08	64.42	62.84	58.25	45.83	56.12
Receivables Turnover TTM	5.86	5.95	5.79	5.48	5.43	5.81	5.98	5.67	5.81	6.27	7.96	6.50
Per Share Metrics
Diluted EPS TTM	-2.80	-2.77	-4.80	-5.03	-2.24	-2.20	-0.11	-0.04	0.01	0.05	-0.12	-0.12
Free Cash Flow Per Share TTM	0.03	-0.08	-0.01	-0.21	-0.20	-0.43	-0.58	-0.35	-0.06	0.08	-0.02	-0.13
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	45.20%	45.98%	46.39%	47.10%	48.79%	49.09%	49.56%	50.19%	50.97%	50.58%	50.10%	49.36%
Operating Profit Margin TTM	-73.05%	-71.25%	-121.70%	-118.59%	-48.21%	-47.07%	4.58%	6.35%	7.43%	7.91%	5.50%	4.56%
Net Profit Margin TTM	-69.94%	-68.47%	-117.61%	-122.06%	-53.55%	-52.12%	-2.58%	-1.02%	0.17%	1.28%	-2.89%	-2.78%
Growth Metrics
Net Revenue Growth (1Y)	-3.92%	-3.67%	-2.77%	-3.20%	-2.50%	-0.53%	-0.75%	12.37%	28.93%	45.66%	73.02%	56.01%
Net Income Growth (1Y)	25.48%	26.54%	4,332.49%	11,491.59%	-31,083.78%	-4,144.22%	-11.45%	-58.81%	-111.61%	-172.57%	-172.93%	-147.34%
EPS Growth (1Y)	25.11%	26.19%	4,321.82%	11,469.52%	-31,021.80%	-4,136.70%	-11.61%	-64.06%	-111.59%	-172.48%	-172.72%	-153.98%
Valuation Metrics
P/E TTM	-4.01	-2.16	-1.20	-1.16	-4.50	-6.45	-158.84	-302.17	2,377.60	311.81	-188.18	-144.45
P/B TTM	1.16	0.62	0.59	0.61	0.82	1.15	1.19	0.91	1.18	1.17	1.59	1.05
P/S TTM	2.81	1.48	1.41	1.42	2.41	3.36	4.10	3.08	4.01	4.00	5.44	4.02
Market Cap	2.44B	1.30B	1.25B	1.27B	2.18B	3.07B	3.74B	2.85B	3.72B	3.67B	5.00B	3.30B
Enterprise Value	3.08B	1.95B	1.90B	2.04B	2.95B	3.83B	4.51B	3.57B	4.45B	4.36B	5.71B	4.03B
Calculated Values
Free Cash Flow TTM	6.05M	-18.47M	-3.15M	-46.35M	-44.21M	-93.09M	-124.88M	-76.16M	-13.19M	16.92M	-5.21M	-24.73M
Net Debt	633.40M	647.59M	653.65M	765.11M	765.41M	752.21M	771.30M	722.67M	728.74M	683.72M	709.99M	722.20M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-17Purchase

Owner: Nassif, Mikheal

Title: CEO

Shares: 23

Price/Share: $10.94

Value: $251.62

Shares Owned: 704

Relationship: Director,Officer

Ownership: Indirect

2026-02-02Purchase

Owner: Nassif, Mikheal

Title: CEO

Shares: 24

Price/Share: $10.00

Value: $240.00

Shares Owned: 681

Relationship: Director,Officer

Ownership: Indirect

2026-01-16Purchase

Owner: Nassif, Mikheal

Title: CEO

Shares: 137

Price/Share: $9.33

Value: $1,278.21

Shares Owned: 632

Relationship: Director,Officer

Ownership: Indirect

2025-11-03Purchase

Owner: Nassif, Mikheal

Title: CEO

Shares: 177

Price/Share: $6.25

Value: $1,106.25

Shares Owned: 495

Relationship: Director,Officer

Ownership: Indirect

2025-05-12Purchase

Owner: Gupta, Aashima

Title: -

Shares: 16,000

Price/Share: $6.25

Value: $100,000.00

Shares Owned: 21,917

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-17	Nassif, Mikheal	Director,Officer	CEO	Indirect	Purchase	23	10.94	$251.62	704	4
2026-02-02	Nassif, Mikheal	Director,Officer	CEO	Indirect	Purchase	24	10.00	$240.00	681	4
2026-01-16	Nassif, Mikheal	Director,Officer	CEO	Indirect	Purchase	137	9.33	$1,278.21	632	4
2025-11-03	Nassif, Mikheal	Director,Officer	CEO	Indirect	Purchase	177	6.25	$1,106.25	495	4
2025-05-12	Gupta, Aashima	Director	-	Direct	Purchase	16,000	6.25	$100,000.00	21,917	4
2025-04-25	Woteki, Catherine E	Director	-	Direct	Purchase	5,770	5.17	$29,830.90	13,244	4
2025-04-24	Borel, James C	Director	-	Direct	Purchase	30,000	4.99	$149,700.00	90,474	4
2025-04-24	Boehm, William T	Director	-	Direct	Purchase	5,000	5.24	$26,200.00	36,214	4
2025-04-23	Rocklin, Amy M	Officer	Chief Legal Officer	Direct	Purchase	12,500	4.99	$62,375.00	36,287	4
2025-04-22	Tobin, James P	Director	-	Direct	Purchase	10,000	4.73	$47,300.00	37,474	4
2025-04-22	Capello, Jeffrey D	Director	-	Direct	Purchase	20,712	4.84	$100,246.08	26,629	4
2025-04-22	Rodriguez, Rafael A	Director	-	Direct	Purchase	7,474	4.59	$34,305.66	14,948	4
2025-04-10	Moylan, John Patrick	Officer	Chief Accounting Officer	Direct	Purchase	10,000	5.07	$50,700.00	10,000	4
2025-01-16	Adent, John Edward	Officer	CEO	Direct	Purchase	23,035	11.03	$254,076.05	269,164	4
2025-01-16	Naemura, David H.	Officer	CFO	Direct	Purchase	14,800	11.11	$164,428.00	61,434	4
2024-10-11	Adent, John Edward	Officer	CEO	Direct	Purchase	14,500	13.80	$200,100.00	216,477	4
2024-08-06	Tobin, James P	Director	-	Direct	Purchase	3,000	16.86	$50,580.00	23,392	4
2024-04-17	Jones, Douglas Edward	Officer	Chief Operating Officer	Direct	Purchase	10,000	12.36	$123,600.00	46,131	4
2024-04-11	Borel, James C	Director	-	Direct	Purchase	7,500	13.06	$97,950.00	21,392	4
2024-04-10	Adent, John Edward	Officer	CEO	Direct	Purchase	23,000	12.36	$284,280.00	152,389	4
2024-04-10	Naemura, David H.	Officer	CFO	Direct	Purchase	12,500	12.51	$156,375.00	30,040	4
2023-11-03	Boehm, William T	Director	-	Direct	Purchase	2,000	16.06	$32,120.00	26,509	4
2023-10-25	Jones, Douglas Edward	Officer	Chief Operating Officer	Direct	Purchase	10,000	15.17	$151,700.00	36,131	4
2023-10-13	Lilly, Jason Warren	Officer	Vice President	Direct	Sale	351	15.10	$5,300.10	26,744	4
2023-10-12	Tobin, James P	Director	-	Direct	Purchase	3,000	15.19	$45,570.00	20,392	4
2023-10-11	Naemura, David H.	Officer	CFO	Direct	Purchase	10,000	15.03	$150,300.00	10,000	4
2023-10-11	Lilly, Jason Warren	Officer	Vice President	Direct	Sale	1,917	15.69	$30,077.73	25,944	4
2023-10-11	Boehm, William T	Director	-	Direct	Sale	2,591	15.61	$40,445.51	24,509	4
2023-08-18	Boehm, William T	Director	-	Direct	Sale	1,500	22.59	$33,885.00	24,509	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

97.49%

Inst. Shares: 212,199,260

Shares Outstanding: 217,668,392

2025-12-31

96.67%

Inst. Shares: 210,176,385

Shares Outstanding: 217,408,270

2025-09-30

106.39%

Inst. Shares: 231,096,172

Shares Outstanding: 217,217,836

2025-06-30

107.61%

Inst. Shares: 233,403,017

Shares Outstanding: 216,894,861

2025-03-31

113.22%

Inst. Shares: 245,733,012

Shares Outstanding: 217,031,907

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	212,199,260	217,668,392	97.49%
2025-12-31	210,176,385	217,408,270	96.67%
2025-09-30	231,096,172	217,217,836	106.39%
2025-06-30	233,403,017	216,894,861	107.61%
2025-03-31	245,733,012	217,031,907	113.22%
2024-12-31	247,619,025	216,813,788	114.21%
2024-09-30	225,132,413	216,695,348	103.89%
2024-06-30	242,709,151	216,481,878	112.12%
2024-03-31	209,898,925	216,597,777	96.91%
2023-12-31	220,463,329	216,410,493	101.87%
2023-09-30	189,924,459	216,309,084	87.80%
2023-06-30	196,831,495	188,880,836	104.21%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

NEOGEN CORP (NEOG) — SEC Financial Statements & Analysis

NEOGEN CORP (NEOG) is a in vitro & in vivo diagnostic substances company, incorporated in MI. NEOGEN CORP trades on NEOG: Nasdaq as: NEOG. Based on its latest SEC filing (Form 10-Q, period ending 2026-02-28), NEOGEN CORP reported a -3.92% year-over-year revenue growth, a Gross Profit Margin of 45.20% (TTM), a Debt-to-Equity ratio of 0.60x, a Price-to-Sales (P/S) ratio of 2.81x (TTM), a Price-to-Book (P/B) ratio of 1.16 (TTM), at a market cap of $2.44B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -3.92%
Gross Profit Margin TTM: 45.20%
Debt To Equity: 0.60x
P/S TTM: 2.81x
P/B TTM: 1.16
Market Cap: $2.44B

Data as of 2026-02-28 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NEOGEN CORP in?

NEOGEN CORP (NEOG) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is NEOG's market cap?

NEOGEN CORP (NEOG) has a market capitalization of $2.44B as of 2026-02-28.

What exchange does NEOG trade on?

NEOGEN CORP (NEOG) trades on the NEOG: Nasdaq.

Where is NEOGEN CORP incorporated?

NEOGEN CORP is incorporated in MI.

NEOGEN CORP (NEOG) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.